A pumpless liver-adipose model for studying metabolic dysfunction and drug responses
PLOS One · 08.05.2026 · 21 (5) · e0345524
DOI: 10.1371/journal.pone.0345524 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.05.2026. Verfasst von Zeinab Ebrahimian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Liver, Adipose Tissue. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Metabolic dysfunction is a primary driver of chronic diseases, such as obesity and type 2 diabetes. Developing in vitro models allows to understand metabolic mechanisms and develop effective treatments. To this end, a pumpless open-top co-culture (POCC) device to simulate liver–adipose tissue interactions was developed. The POCC comprises a four-chamber bioreactor with an open-top configuration and an easy-to-assemble cover cap. Rotational motion enabled perfusion of culture media among the interconnected chambers. HepG2 and 3T3-L1 cells were co-cultured and exposed to olanzapine (Olz), chlorogenic acid (CGA), and metformin (Met) for four days. Drug responses in the POCC were compared with those in 96-well monocultures. Assessments were conducted for glucose/triglyceride (TG) levels, lipid accumulation, and cell viability. While viability remained unchanged, Olz increased lipid content, extracellular glucose and TG levels in the POCC model, effects that CGA and Met mitigated. This practical and physiologically relevant platform offers a promising alternative for preclinical screenings that could be employed to study other multi-tissue interactions in various disease models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Laboratory for Microfluidics and Medical Microsystems, Research Institute for Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- School of Biomedical Engineering, University of British Columbia, Vancouver, Canada.
- Pharmaceutical Research Center, Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Seyed Ali Mousavi Shaegh
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Ebrahimian, Z., Kalalinia, F., Ameri, A. R., Hosseinzadeh, H., Razavi, B. M., & Mousavi Shaegh, S. A. (2026). A pumpless liver-adipose model for studying metabolic dysfunction and drug responses. PLOS One, 21(5), e0345524. https://doi.org/10.1371/journal.pone.0345524
Vancouver
Ebrahimian Z, Kalalinia F, Ameri AR, Hosseinzadeh H, Razavi BM, Mousavi Shaegh SA. A pumpless liver-adipose model for studying metabolic dysfunction and drug responses. PLOS One. 2026;21(5):e0345524. doi:10.1371/journal.pone.0345524
BibTeX
@article{Ebrahimian2026,
author = {Ebrahimian, Zeinab and Kalalinia, Fatemeh and Ameri, Amir Reza and Hosseinzadeh, Hossein and Razavi, Bibi Marjan and Mousavi Shaegh, Seyed Ali},
title = {A pumpless liver-adipose model for studying metabolic dysfunction and drug responses},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0345524},
doi = {10.1371/journal.pone.0345524}
}
EUVIMED